Uusitalo Hannu

Right services to right patients at right time in right setting in Tays Eye Centre.

Revised operational concepts and new facilities together with a 15% increase in work contribution led to a 46% increase in overall productivity, improved access to care and the clearance of delayed services.

Changes in incidence and severity of visual impairment due to glaucoma during 40 years - a register-based study in Finland.

The incidence of reported VI due to glaucoma has increased during the 40 years, but the risk of treated glaucoma patients becoming visually impaired has decreased.

The effect of successful trabeculectomy on the ocular surface and tear proteomics-a prospective cohort study with 1-year follow-up.

Clinical signs as well as the proteomics results indicated that the trabeculectomy and resulting cessation of topical glaucoma medication were very beneficial to the ocular surface.

Oxidized low-density lipoprotein, lipid and calcium aggregates reveal oxidative stress and inflammation in the conjunctiva of glaucoma patients.

The lipid-mediated alterations suggested the presence of oxidative stress and inflammation in the conjunctiva of glaucoma patients.

Association of APOE Haplotypes With Common Age-Related Ocular Diseases in 412,171 Individuals.

Our results support prior evidence of the inverse association of APOE ε4 with glaucoma, but the association was weaker than for AMD.

Association of the MYOC p.(Gln368Ter) Variant With Glaucoma in a Finnish Population.

This genetic association study found that the MYOC p.(Gln368Ter) variant was associated with exfoliation glaucoma.

Comparing glaucoma medications and general demographics in a sample of glaucoma patients treated in private practice with nationwide registry data in Finland.

The study patients were treated effectively by private ophthalmologist. Their medication and the cost of medication were the same as in public clinics. Patients with aggressive glaucoma seem to be generally managed by public hospitals.

Matrix metalloproteinases (MMP-1, MMP-2, MMP-3 and MMP-9, and TIMP-1, TIMP-2 and TIMP-3) and markers for vascularization in functioning and non-functioning bleb capsules of glaucoma drainage implants.

Staining of TIMP-3 was seen to be lower in the vicinity of the small blood vessels.

Conjunctival matrix metalloproteinases and their inhibitors in glaucoma patients.

The expression of MMPs and TIMPs is increased in the conjunctiva of POAG and ExG patients having a long history of topical antiglaucoma drops.